Initial experience evaluating 90yttrium-radiolabeled anti-carcinoembryonic antigen chimeric T84.66 in a phase I radioimmunotherapy trial.
暂无分享,去创建一个
J M Esteban | L E Williams | M. Neumaier | J. Wong | A. Wu | T. Odom-Maryon | J. Shively | F. J. Primus | L. Williams | J. Esteban | M Neumaier | A M Wu | F J Primus | J E Shively | J Y Wong | D M Yamauchi | T Odom-Maryon | D K Johnson | D. Johnson | D. Yamauchi | F. Primus
[1] J. Schlom,et al. Pharmacokinetics and immune response of 131I-chimeric mouse/human B72.3 (human gamma 4) monoclonal antibody in humans. , 1991, Cancer research.
[2] R. Motte. Society of Nuclear Medicine , 1981 .
[3] A. Maraveyas,et al. Asbestos fibers in the colonic wall. , 1974, British Journal of Cancer.
[4] A. Delaloye,et al. Diagnostic Applications and Therapeutic Approaches with Different Preparations of Anti-CEA Antibodies , 1992, The International journal of biological markers.
[5] I. Bernstein,et al. Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support. , 1993, The New England journal of medicine.
[6] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[7] S. Hellman. Isotopic immunoglobulin: a new systemic therapy for advanced Hodgkin's disease. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] H. Hansen,et al. Carcinoembryonic antigen (CEA) assay. A laboratory adjunct in the diagnosis and management of cancer. , 1974, Human pathology.
[9] C. Wagener,et al. Monoclonal antibodies for carcinoembryonic antigen and related antigens as a model system: a systematic approach for the determination of epitope specificities of monoclonal antibodies. , 1983, Journal of immunology.
[10] C. Meares,et al. Conjugation of antibodies with bifunctional chelating agents: isothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ions. , 1984, Analytical biochemistry.
[11] S. Larson,et al. Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy. , 1983, The Journal of clinical investigation.
[12] A. Scott,et al. Lesion-by-lesion comparison of computerized tomography and indium-111-labeled monoclonal antibody C110 radioimmunoscintigraphy in colorectal carcinoma: a multicenter trial. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[13] C. Higano,et al. Colorectal carcinoma: detection with indium-111 anticarcinoembryonic-antigen monoclonal antibody ZCE-025. , 1987, Radiology.
[14] E. Ruoslahti,et al. Carcinoembryonic antigen and alpha fetoprotein in malignant tumors of the female genital tract , 1975, Cancer.
[15] R. V. Van Heertum,et al. Colorectal cancer imaging with iodine-123-labeled CEA monoclonal antibody fragments. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[16] R. Paxton,et al. Estimation of monoclonal antibody-associated 90Y activity needed to achieve certain tumor radiation doses in colorectal cancer patients. , 1990, Cancer research.
[17] S. Hellman. Iodine 131 antiferritin, a new treatment modality in hepatoma: a Radiation Therapy Oncology Group study. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] A. Siccardi,et al. Antibody‐guided diagnosis: An italian experience on cea‐expressing tumours , 1988, International journal of cancer. Supplement = Journal international du cancer. Supplement.
[19] S. Order,et al. Phase I-II studies of yttrium-labeled antiferritin treatment for end-stage Hodgkin's disease, including Radiation Therapy Oncology Group 87-01. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] R. W. Baldwin,et al. The characteristics of blood-borne radiolabels and the effect of anti-mouse IgG antibodies on localization of radiolabeled monoclonal antibody in cancer patients. , 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[21] D. Ettinger,et al. Variable low dose rate irradiation (131I-anti-CEA) and integrated low dose chemotherapy in the treatment of nonresectable primary intrahepatic cholangiocarcinoma. , 1991, International journal of radiation oncology, biology, physics.
[22] J. Ghrayeb,et al. Mouse/human chimeric monoclonal antibody in man: kinetics and immune response. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[23] R. Paxton,et al. Effect of specific antibody pretreatment on liver uptake of 111In-labeled anticarcinoembryonic antigen monoclonal antibody in nude mice bearing human colon cancer xenografts. , 1989, Cancer research.
[24] M. Larché,et al. Development of primary and secondary immune responses to mouse monoclonal antibodies used in the diagnosis and therapy of malignant neoplasms. , 1986, Cancer research.
[25] C. Wagener,et al. Monoclonal antibodies for carcinoembryonic antigen and related antigens as a model system: determination of affinities and specificities of monoclonal antibodies by using biotin-labeled antibodies and avidin as precipitating agent in a solution phase immunoassay. , 1983, Journal of immunology.
[26] Chen-feng Qi,et al. Definition of the expression of the human carcinoembryonic antigen and non‐specific cross‐reacting antigen in human breast and lung carcinomas , 2009, International journal of cancer.
[27] J. Schlom,et al. Purification and composition of the human tumor-associated glycoprotein (TAG-72) defined by monoclonal antibodies CC49 and B72.3. , 1988, Cancer research.
[28] J. Beatty,et al. Comparison of immunoscintigraphy and computerized tomography in identifying colorectal cancer: individual lesion analysis. , 1991, Cancer research.
[29] A Schumitzky,et al. A program package for simulation and parameter estimation in pharmacokinetic systems. , 1979, Computer programs in biomedicine.
[30] A. Riggs,et al. Cloning of the genes for T84.66, an antibody that has a high specificity and affinity for carcinoembryonic antigen, and expression of chimeric human/mouse T84.66 genes in myeloma and Chinese hamster ovary cells. , 1990, Cancer research.
[31] R. Paxton,et al. Preoperative imaging of colorectal carcinoma with 111In-labeled anticarcinoembryonic antigen monoclonal antibody. , 1986, Cancer research.
[32] P. Lind. Application of radioimmunodetection with a radiolabeled monoclonal antibody to CEA (BW 431/26) in colorectal and breast cancer. , 1993, Pathologie-biologie.
[33] J. Simpson,et al. Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patients , 1994, Cancer.
[34] S. Stroupe,et al. An optimized antibody-chelator conjugate for imaging of carcinoembryonic antigen with indium-111. , 1990, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.
[35] M. Kaminski,et al. Radioimmunotherapy of B-cell lymphoma with [131I]anti-B1 (anti-CD20) antibody. , 1993, The New England journal of medicine.
[36] A. Neville,et al. Report of the workshop on the carcinoembryonic antigen (CEA): The present position and proposals for future investigation , 1974, International journal of cancer.
[37] N. Zamcheck,et al. Carcinoembryonic antigen in breast cancer patients: Serum levels and disease progress , 1974, Cancer.